E-ISSN: 1305-3612
Use of transabdominal ultrasound-guided transjugular portal vein puncture on radiation dose in transjugular intrahepatic portosystemic shunt formation
PDF
Cite
Share
Request
Interventional Radiology - Original Article
VOLUME: 23 ISSUE: 3
P: 206-210
May 2017

Use of transabdominal ultrasound-guided transjugular portal vein puncture on radiation dose in transjugular intrahepatic portosystemic shunt formation

Diagn Interv Radiol 2017;23(3):206-210
DOI: 10.5152/dir.2016.15601
Aniket N. Tavare 1
Andrew Wigham 2
Anastasia Hadjivassilou 1
Abdulrahman Alvi 1
Anthie Papadopoulou 1
Antony Goode 1
Nick Woodward 1
David Patch 3
Dominic Yu 1
Neil Davies 1
1. Department of Radiology, Royal Free London NHS Foundation Trust, London, UK
2. Department of Radiology, Oxford University Hospitals NHS Trust, Oxford, UK
3. Department of Hepatology, Royal Free London NHS Foundation Trust, London, UK
No information available.
No information available
Received Date: 25.12.2015
Accepted Date: 09.08.2016
PDF
Cite
Share
Request

ABSTRACT

PURPOSE:

Transjugular intrahepatic portosystemic shunt (TIPS) creation is used to treat portal hypertension complications. Often the most challenging and time-consuming step in the procedure is the portal vein (PV) puncture. TIPS procedures are associated with prolonged fluoroscopy time and high patient radiation exposures. We measured the impact of transabdominal ultrasound guidance for PV puncture on duration of fluoroscopy time and dose.

METHODS:

We retrospectively analyzed the radiation dose for all TIPS performed over a four-year period with transabdominal ultrasound guidance for PV puncture (n=212, with 210 performed successfully and data available for 206); fluoroscopy time, dose area product (DAP) and skin dose were recorded.

RESULTS:

Mean fluoroscopy time was 12 min 9 s (SD, ±14 min 38 s), mean DAP was 40.3±73.1 Gy·cm2, and mean skin dose was 404.3±464.8 mGy.

CONCLUSION:

Our results demonstrate that ultrasound-guided PV puncture results in low fluoroscopy times and radiation doses, which are markedly lower than the only published dose reference levels.